Jaguar Health (JAGX) Assets (2014 - 2026)
Jaguar Health's (JAGX) quarterly Assets came in at $37.4 million in Q1 2026, down 27.26% year-on-year from $51.5 million in Q1 2025, and up 835.85% on a QoQ basis from $4.0 million in Q4 2025.
Jaguar Health (JAGX) Assets (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 13 years of Assets data on file, last reported at $37.4 million in Q1 2026.
- On a quarterly basis, Assets fell 27.26% year-over-year to $37.4 million in Q1 2026; TTM through Mar 2026 was $37.4 million, a 27.26% decrease from a year earlier, with the FY2025 full-year figure at $4.0 million, down 92.51% from the prior year.
- Assets for Q1 2026 stood at $37.4 million, up from $4.0 million in the prior quarter.
- Over the last five years, Assets for JAGX reached as high as $61.5 million in Q2 2024 and fell as low as $4.0 million in Q4 2025.
- Historically, Assets has averaged $48.6 million across 5 years, with a median of $51.3 million in 2022.
- Across the five-year window, Assets climbed 28.84% in 2024 and sank 92.51% in 2025, its largest moves.
- Year by year, Assets stood at $47.5 million in 2022, then rose by 6.98% to $50.8 million in 2023, then climbed by 5.24% to $53.4 million in 2024, then sank by 92.51% to $4.0 million in 2025, then surged by 835.85% to $37.4 million in 2026.
- Per Business Quant data, the three most recent Assets figures were $37.4 million in Q1 2026, $4.0 million in Q4 2025, and $49.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,782.24 Bn | 1,782.18 Bn | - | 77.11 Mn |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | 33.89 Mn |
| 3 | BeOne Medicines | 473.46 Bn | 468.66 Bn | 1.35 Bn | 8.55 Bn |
| 4 | Vertex Pharmaceuticals | 123.84 Bn | 116.59 Bn | 2.59 Bn | 26.48 Bn |
| 5 | Regeneron Pharmaceuticals | 71.69 Bn | 62.94 Bn | 3.31 Bn | 40.87 Bn |
| 6 | Belite Bio | 62.15 Bn | 62.15 Bn | - | 811.27 Mn |
| 7 | Argenx Se | 54.74 Bn | 49.55 Bn | 1.41 Bn | 10.03 Bn |
| 8 | Alnylam Pharmaceuticals | 38.08 Bn | 35.07 Bn | 959.66 Mn | 5.13 Bn |
| 9 | Revolution Medicines | 36.07 Bn | 36.07 Bn | - | 2.25 Bn |
| 10 | Jaguar Health | 520,945.88 | -9.54 Mn | 19.11 Mn | 37.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 37.43 Mn |
| Dec 31, 2025 | 4.00 Mn |
| Sep 30, 2025 | 49.47 Mn |
| Jun 30, 2025 | 48.27 Mn |
| Mar 31, 2025 | 51.46 Mn |
| Dec 31, 2024 | 53.43 Mn |
| Sep 30, 2024 | 58.47 Mn |
| Jun 30, 2024 | 61.46 Mn |
| Mar 31, 2024 | 55.39 Mn |
| Dec 31, 2023 | 50.76 Mn |
| Sep 30, 2023 | 45.38 Mn |
| Jun 30, 2023 | 52.17 Mn |
| Mar 31, 2023 | 56.93 Mn |
| Dec 31, 2022 | 47.45 Mn |
| Sep 30, 2022 | 51.29 Mn |
| Jun 30, 2022 | 49.89 Mn |
| Mar 31, 2022 | 52.91 Mn |
| Dec 31, 2021 | 53.27 Mn |
| Sep 30, 2021 | 59.26 Mn |
| Jun 30, 2021 | 69.54 Mn |